Development of prototype for navigated real-time sonography for the head and neck region
✍ Scribed by Matthias Helbig; Krzysztof Krysztoforski; Pawel Krowicki; Silke Helbig; Wolfgang Gstoettner; Josef Kozak
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 397 KB
- Volume
- 30
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Background.
To date, few imaging methods have been established for the head and neck region, in particular for soft tissues, that allow adequate visualization and simultaneously adequate real‐time orientation.
Methods.
We report a new method using a navigated ultrasound device and a navigated surgical instrument that allows—even in the absence of bony landmarks—appropriate visualization and reliable orientation in real time.
Results.
The practical applicability of the system was tested. Good handling and acceptance of the system could be shown. The “3‐dimensional error” derived from the deviations in all 3 dimensions lies at 0.64 mm.
Conclusions.
With this ultrasound‐guided navigated procedure, an accurate approach of soft tissue structures with a surgical instrument is possible. Changes of the situs are represented in real time. © 2007 Wiley Periodicals, Inc. Head Neck, 2008
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND In the current study, the authors assessed the efficacy of elective radiotherapy in providing regional (lymph node) control in patients with cutaneous melanoma of the head and neck who were at high risk for lymph node involvement. Toxicity was also assessed. ## METHODS
## Abstract ## Objectives: Malignant lymphoma frequently present with cervical lymph node enlargement. Before adequate therapy can be instituted, appropriate biopsy specimens must enable definite subclassification of the disease. While lymph node extirpation, traditionally considered the gold stan
## Abstract ## Background and Objectives Photodynamic therapy is based on an interaction of a drug and light in oxygenated tissue. The photosensitizing drug Foscan® is licensed in the EU for the treatment of advanced head and neck cancer. The light can be applied by surface illumination or directl